1. Home
  2. GPCR vs SONO Comparison

GPCR vs SONO Comparison

Compare GPCR & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • SONO
  • Stock Information
  • Founded
  • GPCR 2016
  • SONO 2002
  • Country
  • GPCR United States
  • SONO United States
  • Employees
  • GPCR N/A
  • SONO N/A
  • Industry
  • GPCR
  • SONO Consumer Electronics/Video Chains
  • Sector
  • GPCR
  • SONO Consumer Discretionary
  • Exchange
  • GPCR Nasdaq
  • SONO Nasdaq
  • Market Cap
  • GPCR 1.1B
  • SONO 1.1B
  • IPO Year
  • GPCR 2023
  • SONO 2018
  • Fundamental
  • Price
  • GPCR $23.82
  • SONO $10.92
  • Analyst Decision
  • GPCR Strong Buy
  • SONO Buy
  • Analyst Count
  • GPCR 9
  • SONO 3
  • Target Price
  • GPCR $77.50
  • SONO $13.00
  • AVG Volume (30 Days)
  • GPCR 1.1M
  • SONO 2.1M
  • Earning Date
  • GPCR 05-08-2025
  • SONO 05-07-2025
  • Dividend Yield
  • GPCR N/A
  • SONO N/A
  • EPS Growth
  • GPCR N/A
  • SONO N/A
  • EPS
  • GPCR N/A
  • SONO N/A
  • Revenue
  • GPCR N/A
  • SONO $1,463,138,000.00
  • Revenue This Year
  • GPCR N/A
  • SONO N/A
  • Revenue Next Year
  • GPCR N/A
  • SONO $5.73
  • P/E Ratio
  • GPCR N/A
  • SONO N/A
  • Revenue Growth
  • GPCR N/A
  • SONO N/A
  • 52 Week Low
  • GPCR $13.22
  • SONO $7.63
  • 52 Week High
  • GPCR $62.74
  • SONO $17.65
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 51.16
  • SONO 63.35
  • Support Level
  • GPCR $25.06
  • SONO $8.73
  • Resistance Level
  • GPCR $27.50
  • SONO $11.42
  • Average True Range (ATR)
  • GPCR 1.86
  • SONO 0.36
  • MACD
  • GPCR -0.31
  • SONO 0.33
  • Stochastic Oscillator
  • GPCR 28.77
  • SONO 81.41

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About SONO Sonos Inc.

Sonos Inc is engaged in providing home sound systems. The company's product profile includes speaker sets and other accessories like boost, mounts, stands, and cables and networking. Geographically, the company operates in the Americas, Europe, the Middle East and Africa and the Asia Pacific. Generating a majority of its revenue from the Americas.

Share on Social Networks: